A condensed cyclic compound represented by Formula 1: ##STR00001## An organic light-emitting device including a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer, and further including at least one of the condensed cyclic compounds of Formula 1.

A condensed cyclic compound represented by Formula 1: ##STR00001## An organic light-emitting device including a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer, and further including at least one of the condensed cyclic compounds of Formula 1.

A cannabis conversion method includes providing a starting material that includes cannabidiol (CBD), combining the starting material with a solvent and a Lewis acid to form a mixture, the solvent and the Lewis acid reacting with the CBD to form a product Delta-8-tetrahydrocannabinol in the mixture, and removing the solvent and the Lewis acid from the mixture, the removing leaving the product Delta-8-tetrahydrocannabinol.

A cannabis conversion method includes providing a starting material that includes cannabidiol (CBD), combining the starting material with a solvent and a Lewis acid to form a mixture, the solvent and the Lewis acid reacting with the CBD to form a product Delta-8-tetrahydrocannabinol in the mixture, and removing the solvent and the Lewis acid from the mixture, the removing leaving the product Delta-8-tetrahydrocannabinol.

Certain embodiments are directed to oridonin analogs or derivatives. In certain aspects, the derivatives are used as anticancer or anti-inflammatory agents.

Certain embodiments are directed to oridonin analogs or derivatives. In certain aspects, the derivatives are used as anticancer or anti-inflammatory agents.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

The present invention generally relates to a process for preparation of 9-halo-3-(2-haloacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one of Formula I, which is an intermediate in the preparation of Hepatitis C Virus (HCV) inhibitors.

The present invention generally relates to a process for preparation of 9-halo-3-(2-haloacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one of Formula I, which is an intermediate in the preparation of Hepatitis C Virus (HCV) inhibitors.